Trial Search
Current Search Criteria:
Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer
N/APoly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
PHASE2This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer
NAThis study aims to evaluate the clinical feasibility of first-line immunoch...
Status
Not Yet Recruiting
Location
The Obstetrics and Gynecology Hospital of Fudan University
Start Date
2025-03-10
Trial ID
NCT06878196
Treatments Being Tested
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer
PHASE2The purpose of this study is to evaluate how the participant's disease (ova...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2009-03
Trial ID
NCT00866723
Treatments Being Tested
Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer
PHASE2This study is phase II, open label, clinical trial to determine the efficac...
Status
Enrolling By Invitation
Location
Yonsei Severance Hospital
Start Date
2020-10-28
Trial ID
NCT04361370
Treatments Being Tested
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
PHASE2Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer
PHASE1This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-03-18
Trial ID
NCT04837716
Treatments Being Tested
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
PHASE3This randomized, Phase III, multicenter, open-label study designed to evalu...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-08-27
Trial ID
NCT03991403
Treatments Being Tested
Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC
PHASE2This is a two-group, parallel, randomized, standard-control phase II study ...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-09-01
Trial ID
NCT05077839
Treatments Being Tested